Vibrio cholerae enterotoxin and its mode of action.
D000469:Alkaline Phosphatase / Q000378:metabolism; D000818:Animals; D000863:Antacids; D001693:Biological Transport, Active / Q000187:drug effects; D002199:Capillary Permeability / Q000187:drug effects; D002463:Cell Membrane Permeability / Q000187:drug effects; D002771:Cholera / Q000188:drug therapy; D002852:Chromatography, Ion Exchange; D000242:Cyclic AMP / Q000627:therapeutic use; D003513:Cycloheximide / Q000627:therapeutic use; D004285:Dogs; D004768:Enterotoxins / Q000096:biosynthesis / Q000302:isolation & purification / Q000494:pharmacology; D004976:Ethacrynic Acid / Q000627:therapeutic use; D006003:Glycogen / Q000378:metabolism; D006801:Humans; D007413:Intestinal Mucosa / Q000187:drug effects; D007421:Intestine, Small / Q000187:drug effects / Q000378:metabolism; D050356:Lipid Metabolism; D008099:Liver / Q000201:enzymology; D008970:Molecular Weight; D011817:Rabbits; D051381:Rats; D012039:Regional Blood Flow / Q000187:drug effects; D014733:Vibrio / Q000378:metabolism; D014882:Water-Electrolyte Balance / Q000187:drug effects
D000863:Antacids; D004768:Enterotoxins; D006003:Glycogen; D003513:Cycloheximide; D000242:Cyclic AMP; D000469:Alkaline Phosphatase; D004976:Ethacrynic Acid